Abstract
Hyperphosphatemia-hyperostosis syndrome (HHS) is a rare autosomal recessive metabolic disorder characterized by elevated serum phosphate levels and repeated attacks of acute, painful swellings of the long bones with radiological evidence of periosteal reaction and cortical hyperostosis. HHS shares several clinical and metabolic features with hyperphosphatemic familial tumoral calcinosis (HFTC), which is caused by mutations in GALNT3 encoding a glycosyltransferase responsible for initiating O-glycosylation. To determine whether GALNT3 is involved in the pathogenesis of HHS we screened two unrelated Arab-Israeli HHS families for pathogenic mutations in this gene. All affected individuals harbored a homozygous splice site mutation (1524+1G↧A) in GALNT3. This mutation was previously described in a large Druze HFTC kindred and has been shown to alter GALNT3 expression and result in ppGalNAc-T3 deficiency. Genotype analysis of six microsatellite markers across the GALNT3 region on 2q24-q31 revealed that the HHS and HFTC families share a common haplotype spanning approximately 0.14 Mb. Our results demonstrate that HHS and HFTC are allelic disorders despite their phenotypic differences and suggest a common origin of the 1524+1G↧A mutation in the Middle East (founder effect). The heterogeneous phenotypic expression of the identified splice site mutation implies the existence of inherited or epigenetic modifying factors of importance in the regulation of ppGalNAc-T3 activity.
Similar content being viewed by others
Abbreviations
- HFTC :
-
Hyperphosphatemic familial tumoral calcinosis
- HHS :
-
Hyperphosphatemia-hyperostosis syndrome
- ppGalNAc-T3 :
-
UDP-N-acetyl-α-d-galactosamine:polypeptide N-acetylgalactosaminyltransferase3
References
Quarles LD (2003) FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization. Am J Physiol Endocrinol Metab 285: E1•E9
Schiavi SC, Kumar R (2004) The phosphatonin pathway: new insights in phosphate homeostasis. Kidney Int 65:1•14
ADHR Consortium (2000) Autosomal dominant hypophosphatemic rickets is associated with mutations in FGF 23. Nat Genet 26:345•348
The HYP Consortium (1995) Agene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. Nat Genet 11:130•136
Prie D, Huart V, Bakouh N, Planelles G, Dellis O, Gerard B, Hulin P, Benque-Blanchet F, Silve C, Grandchamp B, Friedlander G (2002) Nephrolithiasis and osteoporosis associated with hypophosphatemia caused by mutations in the type 2a sodium-phosphate cotransporter. N Engl J Med 347:983•991
Steinherz R, Chesney RW, Eisenstein B, Metzker A, DeLuca HF, Phelps M (1985) Elevated serum calcitriol concentrations do not fall in response to hyperphosphatemia in familial tumoral calcinosis. Am J Dis Child 139:816•819
Melhem RE, Najjar SS, Khachadurian AK (1970) cortical hyperostosis with hyperphosphatemia: a new syndrome? J Pediatr 77:986•990
Clarke E, Swischuk LE, Hayden CK Jr (1984) Tumoral calcinosis, diaphysitis, and hyperphosphatemia. Radiology 151:643•646
Mikati MA, Melhem RE, Najjar SS (1981) The syndrome of hyperostosis and hyperphosphatemia. J Pediatr 99:900•904
Altman HS, Pomerance HH (1971) Cortical hyperostosis with hyperphosphatemia. J Pediatr 79:874•875
Touart DM, Sau P (1998) Cutaneous deposition diseases. II. J Am Acad Dermatol 39:527•544
Topaz O, Shurman DL, Bergman R, Indelman M, Ratajczak P, Mizrachi M, Khamaysi Z, Behar D, Petronius D, Friedman V, Zelikovic I, Raimer S, Metzker A, Richard G, Sprecher E (2004) Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis. Nat Genet 36:579•581
Narchi H (1997) Hyperostosis with hyperphosphatemia: evidence of familial occurrence and association with tumoral calcinosis. Pediatrics 99:745•748
Merril CR (1990) Silver staining of protein and DNA. Nature 343:779•780
Guo SW, Xiong M (1997) Estimating the age of mutant disease alleles based on linkage disequilibrium. Hum Hered 47:315•337
O tm)Connell JR, Weeks DE (1995) The VITESSE algorithm for rapid exact multilocus linkage analysis via genotype set-recoding and fuzzy inheritance. Nat Genet 11:402•408
Kong X, Matise TC (2004) MAP-O-MAP: internet-based linkage mapping. Bioinformatics (epub 16 September 2004)
Dana N (1997) The Druzes (Hebrew). Bar Ilan University Press, Ramat Gan
Ten Hagen KG, Fritz TA, Tabak LA (2003) All in the family: the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases. Glycobiology 13:1R•16R
Acknowledgements
We are grateful to the patients for their participation in our study. We thank Dr. Vered Friedman for outstanding services in DNA sequencing. This study was supported in part by the Chief Scientist Office of the Israeli Ministry of Health (E.S. and R.B.), NIH/NIAMS grants K08-AR02141, P01-AR38923 (G.R.), and K01-HG00055 (D.G.).
Author information
Authors and Affiliations
Corresponding author
Additional information
An erratum to this article can be found at http://dx.doi.org/10.1007/s00109-005-0654-4
Rights and permissions
About this article
Cite this article
Frishberg, Y., Topaz, O., Bergman, R. et al. Identification of a recurrent mutation in GALNT3 demonstrates that hyperostosis-hyperphosphatemia syndrome and familial tumoral calcinosis are allelic disorders. J Mol Med 83, 33–38 (2005). https://doi.org/10.1007/s00109-004-0610-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00109-004-0610-8